In the realm of mole Src homology-2-containing protein tyrosine phosphatase 2 (SHP2) is a member of a human protein phosphatases family (PTPs) and encoded by the PTPN11 cular biology and protein research, the SHP2 peptide has become a significant focal point for investigators studying signal transduction pathways. As a user navigating the complexities of biochemical research, I have found that understanding the structural nuances of this molecule is essential for anyone looking into the mechanisms of cellular signaling.
The Structural Architecture of SHP2
SHP2 is a multi-domain protein tyrosine phosphatase (PTP) that serves as Structures of the SHP2 1-222 tandem domain in the presence and absence of activator peptides, aligned through superposition of the N-SH2 domains (blue). a central player in cellular signaling in animals. Encoded by the *PTPN11* gene, this 593-amino-acid protein is a member of a human protein phosphatases family that is essential for various biological processes.
From my experi May 12, 2020 — The SHP2 structure includes two Src homology 2 domains (N-SH2 and C-SH2) followed by a catalytic protein tyrosine phosphatase (PTP) domain. ence reviewing technical documentation, the most fascinating aspect of SHP2 is its unique configuration, which featur Molecular mechanism of SHP2 activation by PD-1 stimulation es two Src homology 2 domains (N-SH2 and C-SH2) followed by a catalytic protein tyrosine phosphatase (PTP) domain. These SH2 domains are critical mediators of cellular signaling, acting as modules of approximately 100 amino acids that bind to specific phospho (pY)-containing pep Decoding C-SH2 Domain/Peptide Interactions in SH2 Domain tide motifs.
Mechanisms of Activation and Interaction
Scientific literature highlights that SHP2 is a ubiquitous protein tyrosine phosphatase, whose activity is tightly regulated by phosphotyrosine-containing peptides. When we discuss SHP2 peptide interactions, we are often looking at how these motifs induce the proximity of protein tyrosine kinases and facilitate downstream signaling.
A key area of interest is the PD-1-mediated SHP2 activation. Research consistently shows that the structural reorganization of the protein—often triggered by activator peptides—allows it to transition from a basal, inhibited state to an active conformation. This is particularly relevant when considering how bis-phosphorylated peptide SHP2 Peptide ; Applications. Blocking/Control ; Concentration. 10 mg/mL ; Function. Blocking peptides are peptides that bind specifically to the target antibody s can wrangle the SHP2 tandem domains, forcing a conformational shift that exposes the catalytic site.
Applications in Research
For those involved in laboratory analysis, high-quality synthetic versions, such as the human SHP2 synthetic peptide (often cataloged as PEP-0409), are standard tools. These are frequently used as blocking peptides to validate the specificity of antibodies in immunoblotting or immunohistochemistry experiments.
Because SHP2 is a tyrosine phosphatase that plays a regulatory role in multiple intracellular signaling cascades, it is frequently studied in contexts where its dysregulation is suspected. It is widely recognized that SHP2 is implicated in diseases such as cancer and RASopathies, making the study of its binding kinetics a priority for those investigating the interface of cellular growth and signal modulation.
Personal Observations on SHP2 Research
In my own exploration of these molecules, I have observed that the SHP2 phosphatase functions as a pleiotropic factor. This means it can influence multiple signaling pathways simultaneously. When selecting a SHP2 peptide for experimental use, it is vital to ensure the sequence matches the targeted domain—whether that be the N-SH2 or C-SH2—to ensure accurate results in structural studies or inhibition assays.
Furthermore, the "activity-centric" model of SHP2, which was once the standard for explaining pathogenic mutations, has evolved. Modern research now suggests that the structural determinants of phosphopeptide binding are more complex, involving not just simple binding but a sophisticated reorganization of the SH2-SH2 interface.
Conclusion
Whether you are investigating the *PTPN11* gene or the complex biochemical properties of SHP2 mutants, the study of the SHP2 peptide remains a cornerstone of modern molecular research. By focusing on the structural biology of the N-SH2 and C-SH2 domains, researchers can gain deeper insights into how this protein acts as a molecular switch in the cell. As always, rigorous attention to sequence purity and binding specificity is the key to reproducible and meaningful data in this fascina Structures of the SHP2 1-222 tandem domain in the presence and absence of activator peptides, aligned through superposition of the N-SH2 domains (blue). ting field.